DBL Pharmaceuticals Ltd. hosted its 3rd Annual Business Conference on January 11, 2025, at Cox’
DBL pharma recently unveiled Seretrol-F Sykonahaler, which is a technologically advanced Multi-Dose
DBL Pharmaceuticals Ltd. convened its highly anticipated 2nd Annual Business Conference at the prest
Cardiovascular disease is a growing burden and one of the leading causes of death in Bangladesh. In
DBL Pharmaceuticals Ltd. recently held its 1st Annual Business Conference at Hotel Sea Palace, Cox&#
DBL Pharmaceuticals Limited has successfully arranged the first ever Advisory Board Meeting on behal
DBL Group started its journey in the pharmaceutical industry.
DBL Pharma has signed an agreement with GlaxoSmithKline (GSK) Bangladesh Ltd.
DBL Pharmaceutical Inc. an American concern of Bangladeshi DBL Group, has achi...
DBL Pharma celebrates 3rd Annual Business Conference with Vi
DBL Pharmaceuticals Ltd. hosted its 3rd Annual Business Conference on January 11, 2025, at Cox’